Cristian ALvarez
Osorno, Llanquihue, 5290000, Chile
NCT Number: NCT04932642
Concurrent training (CT, characterised by the inclusion of two exercise modalities), is recognised to improve metabolic syndrome (MetS) markers, but little is known about order session effect on interindividual variability. The purpose of the present study was to describe the effects, and the interindividual variability, of 20 weeks of CT in different order at (i.e., high intensity interval training (HIIT) plus resistance training (RT), compared with another group doing RT plus HIIT) in women with severe/morbidly obesity at risk of MetS.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Osorno, Llanquihue, 5290000, Chile
Morbid obesity, defined as a body mass index (BMI) of 40 kg/m2 (class III obesity), is a chronic disease with life-threatening cardiometabolic consequences such as elevated blood pressure (systolic [SBP] or diastolic BP [DBP]), fasting plasma glucose (FPG), triglycerides (Tg), and low high-density lipoprotein cholesterol (HDL-c), all summarised as metabolic syndrome (MetS). In this sense, exercise training as resistance training (RT), defined as any exercise that causes voluntary skeletal muscle contraction by using external weights such as dumbbells and metal bars, is a known non-pharmacotherapy strategy for improving muscle strength and functional capacity in obese patients undergoing bariatric surgery. Similarly, high-intensity interval training (HIIT), defined as several and brief bouts of high-intensity effort usually by cycling/running, interspersed by recovery periods ), has produced strong evidence for the improvement of cardiometabolic risk factors for type 2 diabetes mellitus, arterial hypertension, central arterial stiffness and, vascular function, and cardiorespiratory fitness. Thus, in individuals with morbid obesity, for example, exercise training has proven to be effective for inducing clinically significant weight loss (5-10%), and for the reduction of cardiovascular risk, following the standard recommendations for these cohorts prior to bariatric surgical. However, some inconsistencies have been described after CT, which are directly concerned with the 'order' (i.e. starting the CT session with MICT followed by RT, or vice versa) of the CT session. However, little is known about the interindividual variability of exercise training (IVET) in relation to different order sessions of CT in morbidly obese populations and health-related outcomes, such as MetS markers. Briefly, IVET means that some subjects achieve benefits after training, and are termed responders (Rs), while others exhibit a worsened or unchanged response, and that is commonly known termed as nonresponders (NRs).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each experimental group will be compared with their another contrast order session group
Each experimental group will be compared with their another contrast order session group
Time frame: Baseline to 20-weeks of concurrent training
Component of metabolic syndrome risk factors
Time frame: Baseline to 20-weeks of concurrent training
Component of metabolic syndrome risk factors
Time frame: Component of metabolic syndrome risk factors
Component of metabolic syndrome risk factors
Time frame: Baseline to 20-weeks of concurrent training
Component of metabolic syndrome risk factors
Time frame: Baseline to 20-weeks of concurrent training
Component of metabolic syndrome risk factors
Time frame: Baseline to 20-weeks of concurrent training
Component of metabolic syndrome risk factors
Time frame: Baseline to 20-weeks of concurrent training
Anthropometry parameter related with health and intervention effects. This outcome will be measured by a bio-impedance scale (TANITATM, model 331, Tokyo, Japan).
Time frame: Baseline to 20-weeks of concurrent training
Anthropometry parameter related with health and intervention effects
Time frame: Baseline to 20-weeks of concurrent training
Anthropometry parameter related with health and intervention effects
Time frame: Baseline to 20-weeks of concurrent training
Anthropometry parameter related with health and intervention effects
Time frame: Baseline to 20-weeks of concurrent training
Body composition parameter related with health and intervention effects. This outcome will be measured by a bio-impedance scale (TANITATM, model 331, Tokyo, Japan).
Time frame: Baseline to 20-weeks of concurrent training
Body composition parameter related with health and intervention effects. This outcome will be measured by a bio-impedance scale (TANITATM, model 331, Tokyo, Japan).
Time frame: Baseline to 20-weeks of concurrent training
Metabolic parameter related with health and intervention effects
Time frame: Baseline to 20-weeks of concurrent training
Metabolic parameter related with health and intervention effects
Time frame: Baseline to 20-weeks of concurrent training
Physical fitness outcome related with health and intervention effects. This outcome will be measure using a digital dynamometer (BaselineTM Hydraulic Hand Dynamometers, USA),
Time frame: Baseline to 20-weeks of concurrent training
Physical fitness outcome related with health and intervention effects
Cristian Alvarez
Other
The Effects of Two Different Orders of Concurrent Training on the Interindividual Variability of Health Markers of Metabolic Syndrome and Fitness in Severe/Morbidly Obesity Women. A Randomized Control Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06268990
Body Weight, Diabetes
Graz, Austria
View Trial DetailsNCT02792166
Body Weight, Glucose Metabolism Disorders
Montreal, Quebec, Canada
View Trial DetailsNCT05574049
Body Weight, Dyslipidemias
Clearwater, Florida, United States
View Trial DetailsNCT05504629
Body Weight, Glucose Metabolism Disorders
Temuco, Chile
View Trial Details